Drug safety in Malaysia
This chapter aims to explore the drug (medication)-safety related issues in Malaysia, highlighting present practices and reporting challenges and offering recommendations to overcome the challenges. Malaysia has adequate laws and regulations to monitor and manage drug safety issues. However, there a...
| Published in: | Drug Safety in Developing Countries: Achievements and Challenges |
|---|---|
| Main Author: | |
| Format: | Book chapter |
| Language: | English |
| Published: |
Elsevier
2020
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143375757&doi=10.1016%2fB978-0-12-819837-7.00021-2&partnerID=40&md5=22dbc7b6780356b528dfb6371a6a72c6 |
| id |
2-s2.0-85143375757 |
|---|---|
| spelling |
2-s2.0-85143375757 Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A. Drug safety in Malaysia 2020 Drug Safety in Developing Countries: Achievements and Challenges 10.1016/B978-0-12-819837-7.00021-2 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143375757&doi=10.1016%2fB978-0-12-819837-7.00021-2&partnerID=40&md5=22dbc7b6780356b528dfb6371a6a72c6 This chapter aims to explore the drug (medication)-safety related issues in Malaysia, highlighting present practices and reporting challenges and offering recommendations to overcome the challenges. Malaysia has adequate laws and regulations to monitor and manage drug safety issues. However, there are many challenges facing drug safety in Malaysia. There is an urgent need to improve practices, strengthen medication safety research, and engage health care professionals and patients in medication safety initiatives. © 2020 Elsevier Inc. All rights reserved. Elsevier English Book chapter |
| author |
Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A. |
| spellingShingle |
Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A. Drug safety in Malaysia |
| author_facet |
Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A. |
| author_sort |
Elkalmi R.M.; Al-Worafi Y.M.; Alseragi W.M.; Ming L.C.; Siddique A. |
| title |
Drug safety in Malaysia |
| title_short |
Drug safety in Malaysia |
| title_full |
Drug safety in Malaysia |
| title_fullStr |
Drug safety in Malaysia |
| title_full_unstemmed |
Drug safety in Malaysia |
| title_sort |
Drug safety in Malaysia |
| publishDate |
2020 |
| container_title |
Drug Safety in Developing Countries: Achievements and Challenges |
| container_volume |
|
| container_issue |
|
| doi_str_mv |
10.1016/B978-0-12-819837-7.00021-2 |
| url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143375757&doi=10.1016%2fB978-0-12-819837-7.00021-2&partnerID=40&md5=22dbc7b6780356b528dfb6371a6a72c6 |
| description |
This chapter aims to explore the drug (medication)-safety related issues in Malaysia, highlighting present practices and reporting challenges and offering recommendations to overcome the challenges. Malaysia has adequate laws and regulations to monitor and manage drug safety issues. However, there are many challenges facing drug safety in Malaysia. There is an urgent need to improve practices, strengthen medication safety research, and engage health care professionals and patients in medication safety initiatives. © 2020 Elsevier Inc. All rights reserved. |
| publisher |
Elsevier |
| issn |
|
| language |
English |
| format |
Book chapter |
| accesstype |
|
| record_format |
scopus |
| collection |
Scopus |
| _version_ |
1809678482172542976 |